AC Immune (ACIU) Loans - Net (2018 - 2019)

AC Immune (ACIU) posted quarterly Loans - Net of $101495.1 for Q3 2019, up 103746.03% quarter-over-quarter from $97.74 in Q2 2019.

AC Immune (ACIU) Loans - Net (2018 - 2019) Analysis & Trends

AC Immune (ACIU) has reported Loans - Net for 2 consecutive years, with $101495.1 the latest figure, recorded in Q3 2019.

In Q3 2019, Loans - Net changed N/A year-over-year to $101495.1; the TTM figure through Sep 2019 stood at $101495.1 (changed N/A YoY), while the FY2018 annual figure was $199962.1, changed N/A from the prior year.
Loans - Net grew to $101495.1 in Q3 2019 per ACIU's latest filing, from $97.74 in the prior quarter.
Across five years, Loans - Net topped out at $201816.6 in Q1 2019 and bottomed at $97.74 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Loans (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	AC Immune	253.89 Mn	253.89 Mn	-	-

Download Data